Given that gemcitabine alone had a negligible effect on intra-tumoral CD4:CD8 levels, these data suggest the recruitment and expansion of CD8+ T cells inside the tumor was largely the result of STING activation. The gene discussed is CD8A; the disease is neoplasm.